Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Catalyst Pharmaceuticals Q1 Adj. EPS $0.68 Beats $0.53 Estimate, Sales $141.42M Beat $130.86M Estimate

Author: Benzinga Newsdesk | May 07, 2025 03:50pm
Catalyst Pharmaceuticals (NASDAQ:CPRX) reported quarterly earnings of $0.68 per share which beat the analyst consensus estimate of $0.53 by 28.3 percent. This is a 78.95 percent increase over earnings of $0.38 per share from the same period last year. The company reported quarterly sales of $141.42 million which beat the analyst consensus estimate of $130.86 million by 8.07 percent. This is a 43.56 percent increase over sales of $98.51 million the same period last year.

Posted In: CPRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist